Navigation Links
Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
Date:2/27/2013

PARSIPPANY, N.J., Feb. 27, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company, announced today that Paul Bisaro , Actavis' President and Chief Executive Officer, will provide an overview and update of the Company's business at the Barclays 2013 Global Healthcare Conference on Tuesday, March 12, 2013 at 10:15AM ET at The Loews Miami Hotel in Miami, Florida. The presentation will be webcast live and can be accessed on Actavis' Investor Relations Web site at http://ir.actavis.com.  The webcast can also be accessed at the following URL:

http://cc.talkpoint.com/barc002/031213a_lp/?entity=50_D17TFJP

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Actavis, Inc.Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

Actavis is the world's third-largest generics prescription drug manufacturer.  Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries.  The Company is ranked in the top 3 in 12 global markets, the top 5 in 16 global markets, and in the top 10 in 33 global markets.   Actavis Pharma also develops and out-licen
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
2. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
3. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
4. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
5. MEI Pharma To Present At Cowen And Company Health Care Conference
6. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
7. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Isis Pharmaceuticals To Present At The Cowen and Company 33rd Annual Health Care Conference
9. Taiho Pharmaceutical presenta una solicitud para fabricar y comercializar el nuevo agente antitumoral TAS-102
10. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
11. Zimmer Holdings to Present at Barclays Capital 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014 The legalization of medical and recreational ... as a new economic driver – that has taken ... the right response to the will of the people ... At a National Press Club Newsmakers news conference ... experts in the area of marijuana legalization will discuss ...
(Date:7/14/2014)... 2014 Lumin Medical LLC, a healthcare IT ... the leading provider of on-demand patient tracking solutions and ... to Franklin, Wis. ... light and our mission is to provide visibility for ... and reduce costs," said James Hermann , President ...
(Date:7/14/2014)... 14, 2014 Valeant Pharmaceuticals International, Inc. ... today announced it has filed a premerger notification ... (HSR) with the U.S. Federal Trade Commission (FTC) ... (NYSE: AGN). About Valeant Pharmaceuticals ... Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2Lumin Medical Purchases PatientTrak 2Lumin Medical Purchases PatientTrak 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5
... Approximately ninety-one percent of dentists say patients complaining about dry ... survey conducted by the Academy of General Dentistry (AGD). ... decrease in salivary function. It affects approximately one in ... risk for tooth decay. During the Academy of General Dentistry,s ...
... Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that ... July 9, 2009 at 8:00 am EDT (5:00 am PDT). ... investigator of the trial will discuss results of the Company,s ... the Company,s plans for further development and related matters. ...
Cached Medicine Technology:Dry Mouth Linked to Prescription and Over the Counter Drugs 2Dry Mouth Linked to Prescription and Over the Counter Drugs 3Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 2
(Date:7/14/2014)... 2014 Acute coronary syndrome (ACS) ... healthcare costs, frequent recurrences and hospitalizations, and high ... ACS incidence increases with age and will be ... population increases around the world. ACS is classified ... heart muscle damage inferred from a person’s symptoms, ...
(Date:7/14/2014)... 2014 Midway through summer, throngs of families ... the National Lampoon classic “Vacation.” An estimated four out of ... by Bridgestone Americas , embark on summer road trips. And ... nagging back pain as the result of hours cramped behind ... , “For these patients, riding in a car for an ...
(Date:7/14/2014)... Institutes of Health (NIH) have identified genetic markers associated ... characterized by high levels of immune cells called eosinophils ... are involved in the development of EoE, which can ... allergies. The findings also may help explain why the ... in part by the Consortium of Food Allergy ...
(Date:7/14/2014)... A recent study published in the July 2014 ... of Child and Adolescent Psychiatry confirms the validity ... criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD). , In ... at 7 in DSM-IV, has been raised to 12. ... set at 12, rather than an earlier age, to ...
(Date:7/14/2014)... years that have passed since acupuncture was first ... used to treat a number of physical, mental ... rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia ... Now, a meta-analysis of randomized controlled trials which ... , the journal of The North American Menopause ...
Breaking Medicine News(10 mins):Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 2Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 3Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 4Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 2Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 3Health News:Scientists deepen genetic understanding of eosinophilic esophagitis 2Health News:Bothered by hot flashes? Acupuncture might be the answer 2
... and his colleagues from the Stanford University School of Medicine ... Cancer Research. The result of the study has found that ... to reduce the growth of cancer in patients with prostate ... two drugs reduces the growth of prostate cancer by 70 ...
... researchers from University of South Florida had reported in ... Sciences that the more nature of mental exercise performed ... reducing the risk of dementia in later life.// ... lifetime occupation and risk for Alzheimer’s disease and dementia ...
... Kolkata (6th Sept 2005): In an alarming announcement the ... that West Bengal was facing a Dengue epidemic and the ... last year.// ,Mishra also said that other than ... the people, especially in Kolkata. ,Dengue was also ...
... low dose of Vitamin D with non-steroidal anti- inflammatory ... says a study.// ,David Feldman and other researchers ... a form of Vitamin D, combined with an over-the-counter ... online edition of Ivanhoe Broadcast News. ,The researchers ...
... of had discovered a new way to test the ... attack. // ,The researchers had used a ... cells’ destinations after being injected into the body to ... attack. ,In the study, researchers surgically ...
... from anorexia nervosa have the similar brain activities that ... study was published in the September issue of Archives ... alterations in the activity of serotonin (a brain chemical ... the appetite alteration in anorexia nervosa as well as ...
Cached Medicine News:
... Selecta Duo Adding the ... platform creates the Selecta Duo, ... nm Photocoagulator combination laser that ... involving both the anterior segment ...
Patient-Centered Therapy that promotes natural cardiac function....
... The Apeel CS Catheter Delivery System ... used for the placement of permanent ... Apeel CS Catheter Delivery System is ... torqueability, flexibility, and softness, plus high ...
... Alliance Catheter Delivery System (CDS) ... stabilization of the Aescula LV ... has a patented coronary sinus ... and easy access to the ...
Medicine Products: